News

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

FOX4 talked to Dr. Tracy Stevens about how women have been underrepresented in cardiovascular research and how the new institute plans to make a difference.

On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.

This week, we’re talking about hypertension in younger women and the importance of knowing and staying on top of your blood pressure.

U.S. News & World Report shares results of a new study finding heart disease has plagued humanity for centuries.

KMBC shared results of a new study led by Saint Luke's Mid America Heart Institute finding evidence of heart disease in ancient mummies.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.